 Home > Biochemistry News > Biotechnology News > What are the clinical results of the mRNA vaccine to prevent influenza Moderna?

What are the clinical results of the mRNA vaccine to prevent influenza Moderna?

 Last Update: 2021-12-29
 Source: Internet
 Author: User

Tags

gene expression data

data logger software

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 10, 2021, Moderna announced that its Phase 1 clinical trial of the influenza vaccine mRNA-1010 has obtained positive interim data

The epidemic of seasonal flu causes respiratory diseases and places a huge burden on the healthcare system

However, the current influenza vaccines are only about 40-60% effective, and their formulations were decided 6-9 months before the planned use of the vaccine

This phase 1 clinical trial evaluated the effects of 3 doses of mRNA-1010 (50 µg, 100 µg, and 200 µg) in a cohort of young adults (18-49 years) and elderly (over 50 years)

▲The immunogenicity data of mRNA-1010 in young adults (picture source: Moderna official website)

In the elderly group, compared with baseline, the increase in antibody GMT was 6 times (H1N1), 6 times (H3N2), 3 times (Yamagata), and 2 times (Victoria)

In terms of safety, no serious safety signals were observed

Mr.

Reference materials:

[1] Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.